Revolution Medicines (RVMD) Assets Average (2020 - 2026)

Revolution Medicines has reported Assets Average for 7 years, with the latest figure at $3.3 billion in Q2 2026.

• On a quarterly basis, Assets Average rose 37.17% year-over-year to $3.3 billion in Q2 2026; TTM through Jun 2026 was $3.3 billion, a 37.17% increase from a year earlier, with the FY2025 full-year figure at $2.5 billion, up 6.34% from the prior year.
• Assets Average was $3.3 billion for Q2 2026 at Revolution Medicines, up from $2.3 billion in the prior quarter.
• The five-year high for Assets Average was $3.3 billion in Q2 2026, with the low at $657.8 million in Q2 2022.
• Average Assets Average over 5 years is $1.7 billion, with a median of $1.8 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Assets Average declined 17.03% in 2022, then surged 110.59% in 2024.
• Over 5 years, Assets Average stood at $818.9 million in 2022, then surged by 85.97% to $1.5 billion in 2023, then jumped by 41.87% to $2.2 billion in 2024, then grew by 6.6% to $2.3 billion in 2025, then surged by 42.78% to $3.3 billion in 2026.
• The last three Assets Average figures came in at $3.3 billion (Q2 2026), $2.3 billion (Q1 2026), and $2.3 billion (Q4 2025), per Business Quant data.